GlassScriptPhysician profile
Cheryl A Ellis
NPI 1689819435
$2,056.12
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,945 · 2022: $111.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $326.77 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $229.54 | 2021 | |
| Glaxosmithkline, LLC. | $218.31 | 2021 | |
| Amgen INC. | $181.03 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $160.09 | 2021 | |
| Dexcom, INC. | $94.86 | 2021-2022 | |
| Novo Nordisk INC | $86.55 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $83.95 | 2021 | |
| Lilly USA, LLC | $81.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $78.74 | 2021 | |
| Merck Sharp & Dohme LLC | $66.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $61.60 | 2021 | |
| Pfizer INC. | $42.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.38 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.92 | 2021 | |
| Amarin Pharma, INC. | $36.38 | 2021 | |
| Esperion Therapeutics, INC. | $25.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.83 | 2021 | |
| Mylan Specialty L.P. | $12.53 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.